| Bioactivity | 2',3'-Dideoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | ||||||||||||
| Name | 2',3'-Dideoxyuridine | ||||||||||||
| CAS | 5983-09-5 | ||||||||||||
| Formula | C9H12N2O4 | ||||||||||||
| Molar Mass | 212.20 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2',3'-Dideoxyuridine
CAS: 5983-09-5 F: C9H12N2O4 W: 212.20
2',3'-Dideoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting in
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.